STERIS plc (STE)
Gross profit margin
Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 2,218,160 | 1,980,730 | 2,016,360 | 1,343,100 | 1,320,000 |
Revenue | US$ in thousands | 5,138,700 | 4,536,270 | 4,585,060 | 3,107,520 | 3,030,900 |
Gross profit margin | 43.17% | 43.66% | 43.98% | 43.22% | 43.55% |
March 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $2,218,160K ÷ $5,138,700K
= 43.17%
The gross profit margin of STERIS plc has exhibited consistency over the past five years, ranging between 43.17% and 43.98%. Despite minor fluctuations, the margins have remained relatively stable, indicating the company's ability to effectively manage its cost of goods sold and generate profits from its core operations. This trend reflects STERIS plc's strength in controlling production and distribution costs, ultimately contributing to a healthy gross profit margin. It suggests that the company has maintained a competitive pricing strategy while efficiently managing its production processes.
Peer comparison
Mar 31, 2024
Company name
Symbol
Gross profit margin
STERIS plc
STE
43.17%
Align Technology Inc
ALGN
70.08%
Avanos Medical Inc
AVNS
64.63%
Edwards Lifesciences Corp
EW
77.11%
Intuitive Surgical Inc
ISRG
62.10%
MSA Safety
MSA
47.67%
Zimmer Biomet Holdings Inc
ZBH
18.09%